Actively Recruiting
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Led by University of California, San Francisco · Updated on 2025-05-15
30
Participants Needed
1
Research Sites
194 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
T
The ZOLL Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
RESTORE is a randomized clinical trial investigating the safety and feasibility of using EEG treatment targets (burst suppression vs. seizure suppression) for post-cardiac arrest refractory status epilepticus treatment.
CONDITIONS
Official Title
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Non-traumatic, out-of-hospital cardiac arrest
- Comatose on admission, defined as not following commands
- Return of spontaneous circulation within less than 45 minutes
- Admission to the intensive care unit
- Diagnosis of post-cardiac arrest refractory status epilepticus confirmed with continuous EEG monitoring within 7 days from return of spontaneous circulation
You will not qualify if you...
- Acute cerebral hemorrhage or infarction
- Pregnancy
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110
Actively Recruiting
Research Team
E
Edilberto Amorim, MD
CONTACT
K
Kevin Bao
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here